Uveitis-related factors in patients with spondyloarthritis: TReasure real-life results
NŞY Bilge, U Kalyoncu, P Atagündüz, E Dalkılıç… - American Journal of …, 2021 - Elsevier
Purpose Spondyloarthritis (SpA) is a group of diseases with overlapping skeletal and extra-
articular features. Acute anterior uveitis (AAU) is the most common extra-articular …
articular features. Acute anterior uveitis (AAU) is the most common extra-articular …
Preferences of inflammatory arthritis patients for biological disease-modifyingantirheumatic drugs in the first 100 days of the COVID-19 pandemic
U Kalyoncu, Y Pehlivan, S Akar… - Turkish journal of …, 2021 - journals.tubitak.gov.tr
Background/aim: To evaluate treatment adherence and predictors of drug discontinuation
among patients with inflammatory arthritis receiving bDMARDs within the first 100 days after …
among patients with inflammatory arthritis receiving bDMARDs within the first 100 days after …
The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up study
B Yagiz, N Lermi, BN Coskun, E Dalkilic, S Kiraz… - …, 2023 - academic.oup.com
Objectives The objectives of this study were to assess the clinical characteristics, predictive
factors, and practical algorithms of paradoxical reactions (PRs), specifically paradoxical …
factors, and practical algorithms of paradoxical reactions (PRs), specifically paradoxical …
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from …
Ö KARADAĞ, B Farisogullari, B YAĞIZ… - Clinical and …, 2024 - avesis.mku.edu.tr
To evaluate the retention rate, treatment response and safety of tocilizumab (TCZ) as first-
line biologic treatment in rheumatoid arthritis (RA) patients with inadequate response to …
line biologic treatment in rheumatoid arthritis (RA) patients with inadequate response to …
Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database
Objectives This study aimed to evaluate the hepatitis B (HBV) and C (HCV) frequency and
clinical characteristics among patients with rheumatoid arthritis (RA) or spondyloarthritis …
clinical characteristics among patients with rheumatoid arthritis (RA) or spondyloarthritis …
In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
B Yagiz, BN Coskun, Y Pehlivan, E Dalkilic… - Rheumatology …, 2021 - Springer
We wanted to see how close we could get to our goal of treating rheumatoid arthritis (RA)
without the use of glucocorticoids (GCs) in the disease-modifying antirheumatic drugs …
without the use of glucocorticoids (GCs) in the disease-modifying antirheumatic drugs …
Physicians' Biological Drug Preference in Patients With Rheumatoid Arthritis and Spondyloarthritis With a History of Malignancy: Perspectives From the Treasure …
E Tekgoz, S Colak, KG Yardimci… - JCR: Journal of …, 2022 - journals.lww.com
Objective Because of concerns about malignancy risks, using biological disease-modifying
antirheumatic drugs (bDMARDs) in patients with a history of malignancy remains a …
antirheumatic drugs (bDMARDs) in patients with a history of malignancy remains a …
[HTML][HTML] The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database
NA Kanıtez, S Kiraz, E Dalkılıç, G Kimyon… - European Journal of …, 2022 - ncbi.nlm.nih.gov
Objective: The coronavirus disease 2019 pandemic has been resulting in increased hospital
occupancy rates. Rheumatic patients cannot still reach to hospitals, or they hesitate about …
occupancy rates. Rheumatic patients cannot still reach to hospitals, or they hesitate about …
Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
U İlgen, Ö Karadağ, H Emmungil, O Küçükşahin… - Rheumatology …, 2022 - Springer
This study aimed to compare Tuberculin Skin Test (TST) and QuantiFERON®-TB Gold In-
Tube (QFT–GIT) test in rheumatoid arthritis (RA) and spondyloarthritis (SpA) patients …
Tube (QFT–GIT) test in rheumatoid arthritis (RA) and spondyloarthritis (SpA) patients …
Muscle ultrasound in Spondyloarthritis patients receiving biologic disease-modifying anti-rheumatic drugs early in treatment
M Hafızoğlu, Z Özsoy, ZÖ Öztürk, M Ekici… - Clinical Science of …, 2024 - clinscinutr.org
Objective: This study evaluated muscle ultrasound in spondyloarthritis (SpA) patients
receiving biologic disease-modifying anti-rheumatic drugs (b-DMARDs) early in treatment …
receiving biologic disease-modifying anti-rheumatic drugs (b-DMARDs) early in treatment …